Extended cognitive behavior therapy for cigarette smoking cessation.

PRIMARY AIM: Examine the effectiveness of extended cognitive behavior therapy (CBT) in promoting longer-term smoking abstinence. DESIGN: Open-label treatment phase followed by extended treatment phase. Randomization conducted prior to entry into open-label treatment phase; analysis based on intentio...

Full description

Bibliographic Details
Published in:Addiction Vol. 103; no. 8; pp. 1381 - 1391
Main Authors: Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M
Format: clinical trial research tables/charts Journal Article
Published: Wiley-Blackwell Aug2008
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105674556&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105674556
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: Aug2008
      vid: 103
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        105674556
        2010037495
        10.1111/j.1360-0443.2008.02273.x
        NLM18855829
        105674556
      ppf: 1381
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Extended cognitive behavior therapy for cigarette smoking cessation.
      aug:
        au:
          Killen JD
          Fortmann SP
          Schatzberg AF
          Arredondo C
          Murphy G
          Hayward C
          Celio M
          Cromp D
          Fong D
          Pandurangi M
        affil: Stanford University School of Medicine, Hoover Pavilion, Quarry Road, Stanford, CA, USA
      sug:
        subj:
          Bupropion Therapeutic Use
          Cognitive Therapy
          Nicotine Patch Therapeutic Use
          Smoking Cessation
          Smoking Therapy
          Telehealth
          Adolescence
          Adult
          Aged
          Breath Tests
          Bupropion Adverse Effects
          Center for Epidemiological Studies Depression Scale
          Chi Square Test
          Clinical Trials
          Combined Modality Therapy
          Confidence Intervals
          Descriptive Statistics
          Drug Therapy, Combination
          Female
          Funding Source
          Interview Guides
          Logistic Regression
          Male
          Middle Age
          Nicotine Patch Adverse Effects
          Odds Ratio
          Prevalence
          Psychological Tests
          Questionnaires
          Recurrence Prevention and Control
          Scales
          Self Report
          Sex Factors
          Smoking Drug Therapy
          Structured Interview
          Support, Psychosocial
          Treatment Outcomes
          Human
          Adolescent: 13-18 years
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: PRIMARY AIM: Examine the effectiveness of extended cognitive behavior therapy (CBT) in promoting longer-term smoking abstinence. DESIGN: Open-label treatment phase followed by extended treatment phase. Randomization conducted prior to entry into open-label treatment phase; analysis based on intention-to-treat to avoid threat of selection bias. SETTING: Community smoking cessation clinic. PARTICIPANTS: A total of 304 adult smokers (> or = 18 years of age; > or = 10 cigarettes/day). INTERVENTION: Open-label (8 weeks): all participants received bupropion SR, nicotine patch, CBT. Extended treatment (12 weeks): participants received either CBT + voicemail monitoring and telephone counseling or telephone-based general support. MEASUREMENTS: Seven-day point prevalence abstinence, expired-air carbon monoxide. RESULTS: At week 20 follow-up, CBT produced a higher 7-day point prevalence abstinence rate: 45% versus 29%, P = 0.006; at 52 weeks the difference in abstinence rates (31% versus 27%) was not significant. History of depression was a moderator of treatment. Those with a positive history had a better treatment response at 20 weeks when assigned to the less intensive telephone support therapy (P < 0.05). CONCLUSION: The superiority of CBT to 20 weeks suggests that continued emphasis on the development of cognitive and behavioral strategies for maintaining non-smoking during an extended treatment phase may help smokers to maintain abstinence in the longer term. At present, the minimum duration of therapy is unknown.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N